Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

<div>Prognostic value of the risk score and other pathological parameters in LUAD. (a) Nomogram survival prediction chart for predicting OS rates at 3 and 5 years. (b) Calibration curve of the nomogram in the TCGA database LUAD dataset.</div>

Analytical Cellular Pathology

fig9

Figure 9

Figure 9: Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 

Figure 9 | Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 